Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial ...

Shortly after Alkermes and Avadel announced their deal, Lundbeck made an unsolicited offer of $23 per share, including $21 ...

Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...

The document, from the US-China Economic and Security Review Commission, warns that if China did choose to restrict access to ...

The approval puts Lunsumio on the same footing as Epkinly (epcoritamab) in FL – a form of non-Hodgkin lymphoma (NHL) – as ...

The role of Medical Affairs within the pharmaceutical industry is to generate and disseminate evidence to healthcare ...

Moderated by pharmaphorum’s web editor Nicole Raleigh, the session featured three expert panellists: Mo Rice, Vice President ...

With new technologies that allow drugs to be tested directly in human biological systems, researchers are beginning to ...

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio ...

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and ...

According to GSK, the programme of 'Grand Challenge' research projects will make use of AI and other cutting-edge ...